NDC 12634-687 Phentermine Hydrochloride

The NDC code 12634-687 is assigned by the FDA to the product Phentermine Hydrochloride which is product labeled by Apotheca Inc.. The product's dosage form is . The product is distributed in 37 packages with assigned NDC codes 12634-687-00 10 tablet in 1 bottle , 12634-687-01 100 tablet in 1 bottle , 12634-687-09 35 tablet in 1 bottle , 12634-687-40 40 tablet in 1 bottle , 12634-687-42 42 tablet in 1 bottle , 12634-687-45 45 tablet in 1 bottle , 12634-687-50 50 tablet in 1 bottle , 12634-687-52 12 tablet in 1 blister pack , 12634-687-54 14 tablet in 1 blister pack , 12634-687-57 20 tablet in 1 blister pack , 12634-687-58 28 tablet in 1 blister pack , 12634-687-59 30 tablet in 1 blister pack , 12634-687-60 60 tablet in 1 bottle , 12634-687-61 10 tablet in 1 blister pack , 12634-687-63 3 tablet in 1 blister pack , 12634-687-66 6 tablet in 1 blister pack , 12634-687-67 7 tablet in 1 blister pack , 12634-687-69 9 tablet in 1 blister pack , 12634-687-71 30 tablet in 1 bottle , 12634-687-74 24 tablet in 1 bottle , 12634-687-78 28 tablet in 1 bottle , 12634-687-79 25 tablet in 1 bottle , 12634-687-80 20 tablet in 1 bottle , 12634-687-81 21 tablet in 1 bottle , 12634-687-82 12 tablet in 1 bottle , 12634-687-84 14 tablet in 1 bottle , 12634-687-85 15 tablet in 1 bottle , 12634-687-90 90 tablet in 1 bottle , 12634-687-91 1 tablet in 1 blister pack , 12634-687-92 2 tablet in 1 bottle , 12634-687-93 3 tablet in 1 bottle , 12634-687-94 4 tablet in 1 bottle , 12634-687-95 5 tablet in 1 bottle , 12634-687-96 6 tablet in 1 bottle , 12634-687-97 7 tablet in 1 bottle , 12634-687-98 8 tablet in 1 bottle , 12634-687-99 9 tablet in 1 bottle . This page includes all the important details about this product, including active and inactive ingredients, pharmagologic classes, product uses and characteristics, UNII information and RxNorm crosswalk.

Phentermine hydrochloride is indicated as a short-term (a few weeks) adjunct in a regimen of weight reduction based on exercise, behavioral modification and caloric restriction in the management of exogenous obesity for patients with an initial body mass index ≥ 30 kg/m 2, or ≥ 27 kg/m 2 in the presence of other risk factors (e.g., controlled hypertension, diabetes, hyperlipidemia). Below is a chart of body mass index (BMI) based on various heights and weights.BMI is calculated by taking the patient's weight, in kilograms (kg), divided by the patient's height, in meters (m), squared. Metric conversions are as follows:pounds ÷ 2.2 = kg; inches × 0.0254 = meters.BODY MASS INDEX (BMI), kg/m 2The limited usefulness of agents of this class, including phentermine hydrochloride tablets, [ see Clinical Pharmacology (12.1, 12.2)] should be measured against possible risk factors inherent in their use such as those described below.

RxNorm is a normalized naming system for generic and branded drugs that assigns unique concept identifier(s) known as RxCUIs to NDC products.The NDC to RxNorm Crosswalk for this produdct indicates multiple concept unique identifiers (RXCUIs) are associated with this product:

• RxCUI: 803353 - phentermine HCl 37.5 MG Oral Tablet
• RxCUI: 803353 - phentermine hydrochloride 37.5 MG Oral Tablet
• RxCUI: 803353 - phentermine hydrochloride 37.5 MG (equivalent to phentermine 30 MG) Oral Tablet